These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18165208)

  • 1. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.
    Paterna S; Parrinello G; Di Pasquale P; Torres D; La Rocca G; Antona R; Vernuccio L; Fornaciari E; Tarantino A; Piccione E; Fasullo S; Licata G
    Adv Ther; 2007; 24(6):1260-70. PubMed ID: 18165208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.
    Parrinello G; Paterna S; Torres D; Di Pasquale P; Mezzero M; La Rocca G; Cardillo M; Trapanese C; Caradonna M; Licata G
    Clin Drug Investig; 2009; 29(9):591-600. PubMed ID: 19663521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.
    Leeman M; van de Borne P; Collart F; Vandenhoven G; Peeters L; Mélot C; Degaute JP
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):785-91. PubMed ID: 7509894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B; Song WH; Liu GZ;
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).
    Czuriga I; Riecansky I; Bodnar J; Fulop T; Kruzsicz V; Kristof E; Edes I; ;
    Cardiovasc Drugs Ther; 2003 May; 17(3):257-63. PubMed ID: 14574084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity.
    Brion R; Carré F; Verdier JC; Poncelet P; Douard H; Page E; Amoretti R; Gauthier J; Ducardonnet A; Gressin V; Dubanchet A
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):78-83. PubMed ID: 10630736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.
    Suojanen L; Haring A; Tikkakoski A; Koskela JK; Tahvanainen AM; Huhtala H; Kähönen M; Sipilä K; Eräranta A; Mustonen JT; Kivistö K; Pörsti IH
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):130-137. PubMed ID: 28256104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
    Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
    Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
    Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
    Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D; Koch EM; Gottwald-Hostalek U
    Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
    Giesecke HG; Buchner-Möll D
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S175-8. PubMed ID: 11527123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life comparison between bisoprolol and nifedipine retard in hypertension.
    de Hoon JN; Vanmolkot FH; van de Ven LL; Van Bortel LM
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):465-71. PubMed ID: 9310275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner HR; Burnier M
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.